SD

Saroj Dilbagi

Director Director DIN 02606847
DIN 02606847 First appointment Mar 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2009
Shareholding value Locked Premium profile

About Saroj Dilbagi

Data last updated:

Saroj Dilbagi has 17 years in corporate governance. Formerly with 1 company, such as Curet Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 02606847
Primary Designation Director
First Appointment 10 Mar 2009
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Curet Pharmaceuticals Pvt Ltd U24232CH1994PTC015380
Whole-Time Director10 Mar 20091994Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Curet Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Saroj Dilbagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Dilbagi

Saroj Dilbagi has 17 years in corporate governance. Formerly with 1 company, such as Curet Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

Saroj Dilbagi is associated with 0 companies as a director.

Saroj Dilbagi has expertise in General Business.

Saroj Dilbagi has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available